European Journal of Drug Metabolism and Pharmacokinetics 1987-01-01

Metabolism of [14C]2-aminobiphenyl in vivo by different species.

M Kajbaf, J W Gorrod

Index: Eur. J. Drug Metab. Pharmacokinet. 12(4) , 285-90, (1987)

Full Text: HTML

Abstract

[14C] 2-Aminobiphenyl is predominantly metabolised in vivo to 3- and 5-hydroxy conjugated derivatives in all species. In some species, 2-aminobiphenyl is also excreted to a small extent as N-conjugated derivatives. Renal excretion accounts for about 30-40% of the administered dose during the first 24 hours. The 5-O-sulphate and 5-O-glucuronide of 2-amino-5-hydroxybiphenyl have been found as major metabolites with all species; 2-amino-3-hydroxybiphenyl-O-sulphate is also a significant metabolite. There were metabolic differences observed between species in this study. HPLC and TLC analytical techniques were used for separation and detection of [14C] 2-aminobiphenyl and its metabolites. Formation of different isomeric metabolites may be explained by electronic Hückel molecular orbital calculations and stereochemical factors.

Related Compounds

  • 3-Biphenylamine

Related Articles:

Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.

1988-12-01

[Proc. Natl. Acad. Sci. U. S. A. 85(24) , 9788-91, (1988)]

Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.

1988-01-01

[IARC Sci. Publ. (89) , 133-6, (1988)]

Elevated blood levels of carcinogens in passive smokers.

1989-10-01

[Am. J. Public Health 79(10) , 1381-4, (1989)]

Nonsmoking-related arylamine exposure and bladder cancer risk.

2003-06-01

[Cancer Epidemiol. Biomarkers Prev. 12(6) , 503-7, (2003)]

Haemoglobin adducts formed by aromatic amines in smokers: sources of inter-individual variability.

1990-04-01

[Br. J. Cancer 61(4) , 534-7, (1990)]

More Articles...